Zobrazeno 11 - 20
of 606
pro vyhledávání: '"Colin P.N. Dinney"'
Autor:
Anirban P. Mitra, Sharada Mokkapati, Tanner S. Miest, Vikram M. Narayan, Richard Philipson, Seppo Yla-Herttuala, David Sawutz, Nigel R. Parker, David J. McConkey, Colin P.N. Dinney
Publikováno v:
Journal of Urology. 207
Autor:
Neema Navai, Nathan A. Brooks, Colin P.N. Dinney, Justin T. Matulay, Patrick J. Hensley, Ashish M. Kamat, Kelly K. Bree, Graciela M. Nogueras González, Roger Li, Surena F. Matin, H. B. Grossman
Publikováno v:
BJU International. 128:568-574
OBJECTIVE To evaluate the impact of upper tract urothelial carcinoma (UTUC) on bacillus Calmette-Guerin (BCG) response and progression in patients with non-muscle-invasive bladder cancer (NMIBC). PATIENTS AND METHODS We performed an institutional rev
Autor:
Alan Boyd, Tracy M. Downs, Brian R. Lane, Michael Woods, Brant A. Inman, Joseph Mashni, Gary D. Steinberg, Kirk A. Keegan, Alexander Sankin, Joseph E. Busby, Stephen A. Boorjian, Robert S. Svatek, Richard Philipson, Paul L. Crispen, Michael A. O’Donnell, Seth P. Lerner, Daniel J. Canter, Colin P.N. Dinney, Vikram M. Narayan, Yair Lotan, Tracey L. Krupski, Michael S. Cookson, Leonard G. Gomella, Ashish M. Kamat, David Sawutz, Lawrence Karsh, Michael B. Williams, F. Peter Treasure, Ruth Coll, Gennady Bratslavsky, Thomas J. Guzzo, Adam Luchey, Mehrdad Alemozaffar, Trinity J. Bivalacqua, Michael A. Poch, Jeffrey S. Montgomery, Badrinath R. Konety, Nigel Parker, Anne Schuckman, Seppo Ylä-Herttuala, Neal D. Shore, Gordon D. Brown, Gerald L. Andriole
Publikováno v:
The Lancet Oncology. 22:107-117
Summary Background BCG is the most effective therapy for high-risk non-muscle-invasive bladder cancer. Nadofaragene firadenovec (also known as rAd-IFNa/Syn3) is a replication-deficient recombinant adenovirus that delivers human interferon alfa-2b cDN
Autor:
Weranja Ranasinghe, Lianchen Xiao, H. Barton Grossman, Roger Li, Colin P.N. Dinney, Neema Navai, Jianjun Gao, Justin T. Matulay, Yu Shen, Andrea Kokorovic, Nathan A. Brooks, Supriya Nagaraju, Ashish M. Kamat
Publikováno v:
BJU International. 128:65-71
OBJECTIVES To evaluate if the obesity paradox, wherein obesity portends worse overall prognosis for a disease but improved outcomes for patients receiving immunotherapy, exists for patients receiving bacillus Calmette-Guerin (BCG) in a contemporary c
Autor:
Surena F. Matin, Andrew C. Thorpe, Wassim Kassouf, Colin P.N. Dinney, Andrew J. Stephenson, Trinity J. Bivalacqua, Yair Lotan, Firas G. Petros, Marc A. Dall'Era, Homayoun Zargar, Todd M. Morgan, Peter C. Black, Jonathan L. Wright, Shahrokh F. Shariat, Philippe E. Spiess, Srikala S. Sridhar, John S. McGrath, Daniel A. Barocas, David D'Andrea, Michael S. Cookson, Jeffrey M. Holzbeierlein, Bas W.G. van Rhijn, Scott North, Siamak Daneshmand
Publikováno v:
Bju International
OBJECTIVE To assess the differential response to neoadjuvant chemotherapy (NAC) in patients with urothelial carcinoma of the bladder (UCB) compared to upper tract urothelial carcioma (UTUC) treated with radical surgery. PATIENTS AND METHODS Data from
Autor:
Anirban P. Mitra, Vikram M. Narayan, Sharada Mokkapati, Tanner Miest, Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella, Ashish M. Kamat, Trinity J. Bivalacqua, Jeffrey S. Montgomery, Seth P. Lerner, J. Erik Busby, Michael Poch, Paul L. Crispen, Gary D. Steinberg, Anne K. Schuckman, Tracy M. Downs, Robert S. Svatek, Joseph Mashni, Brian R. Lane, Thomas J. Guzzo, Gennady Bratslavsky, Lawrence I. Karsh, Michael E. Woods, Gordon A. Brown, Daniel Canter, Adam Luchey, Yair Lotan, Tracey Krupski, Brant A. Inman, Michael B. Williams, Michael S. Cookson, Kirk A. Keegan, Gerald L. Andriole, Alexander I. Sankin, Alan Boyd, Michael A. O'Donnell, Richard Philipson, Seppo Ylä-Herttuala, David Sawutz, Nigel R. Parker, David J. McConkey, Colin P.N. Dinney
Publikováno v:
Eur Urol
A recent phase 3 trial of intravesical nadofaragene firadenovec reported a promising complete response rate for patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer. This study examined the ability of antiadenovirus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9deece93273da2ab7b3a339994b2f19
https://europepmc.org/articles/PMC8891058/
https://europepmc.org/articles/PMC8891058/
Autor:
Niyati Lobo, Graciela M. Nogueras-Gonzalez, Patrick J. Hensley, Colin P.N. Dinney, Kelly K. Bree, Ashish M. Kamat, Neema Navai
Publikováno v:
BJU internationalReferences. 130(4)
OBJECTIVE Previous reports attempting to evaluate the clinical efficacy of intravesical bacillus Calmette-Guerin (BCG) therapy in patients taking fibrin clot inhibitors (FCI) have yielded conflicting results and are primarily based on patient cohorts
Autor:
Colin P.N. Dinney, Ashish M. Kamat, Kelly K. Bree, Graciela M. Nogueras-Gonzalez, Patrick J. Hensley, Prasanth Abraham, Neema Navai, Niyati Lobo
Publikováno v:
BJU internationalReferences. 130(3)
Objective The global bacillus Calmette-Guerin (BCG) shortage has prompted the use of alternative treatment strategies for patients with intermediate- and high-risk non-muscle invasive bladder cancer (NMIBC). One such strategy is split-vial dosing whi
Autor:
S.F. Shariat, Scott North, Joshua Griffin, Andrew J. Stephenson, Jonathan Aning, Petros Grivas, Maria Carmen Mir, Todd M. Morgan, H. Zargar, Michael S. Cookson, Nikhil Vasdev, Trinity J. Bivalacqua, B.W.G. Van Rhijn, D. A. Barocas, Jeffrey M. Holzbeierlein, Yair Lotan, A. Fairey, Michele Marchioni, Marc A. Dall'Era, Kamran Zargar-Shoshtari, D. Daneshmand, Wassim Kassouf, John S. McGrath, Srikala S. Sridhar, Jonathan L. Wright, Philippe E. Spiess, Andrew C. Thorpe, Laura-Maria Krabbe, Colin P.N. Dinney, Jay B. Shah, Laura S. Mertens, Evan Y. Yu, Niels Jacobsen, Evanguelos Xylinas, Jeffrey S. Montgomery, Peter C. Black
Publikováno v:
European Urology Focus, 7(6), 1347-1354. Elsevier BV
Mir, M C, Marchioni, M, Zargar, H, Zargar-Shoshtari, K, Fairey, A S, Mertens, L S, Dinney, C P, Krabbe, L M, Cookson, M S, Jacobsen, N E, Griffin, J, Montgomery, J S, Vasdev, N, Yu, E Y, Xylinas, E, McGrath, J S, Kassouf, W, Dall'Era, M A, Sridhar, S S, Aning, J, Shariat, S F, Wright, J L, Thorpe, A C, Morgan, T M, Holzbeierlein, J M, Bivalacqua, T J, North, S, Barocas, D A, Lotan, Y, Grivas, P, Stephenson, A J, Shah, J B, van Rhijn, B W, Spiess, P E, Daneshmand, D & Black, P C 2021, ' Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer : Results of an International Consortium ', European Urology Focus, vol. 7, no. 6, pp. 1347-1354 . https://doi.org/10.1016/j.euf.2020.07.002
Mir, M C, Marchioni, M, Zargar, H, Zargar-Shoshtari, K, Fairey, A S, Mertens, L S, Dinney, C P, Krabbe, L M, Cookson, M S, Jacobsen, N E, Griffin, J, Montgomery, J S, Vasdev, N, Yu, E Y, Xylinas, E, McGrath, J S, Kassouf, W, Dall'Era, M A, Sridhar, S S, Aning, J, Shariat, S F, Wright, J L, Thorpe, A C, Morgan, T M, Holzbeierlein, J M, Bivalacqua, T J, North, S, Barocas, D A, Lotan, Y, Grivas, P, Stephenson, A J, Shah, J B, van Rhijn, B W, Spiess, P E, Daneshmand, D & Black, P C 2021, ' Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer : Results of an International Consortium ', European Urology Focus, vol. 7, no. 6, pp. 1347-1354 . https://doi.org/10.1016/j.euf.2020.07.002
Background:: Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) is associated with improved overall and cancer-specific survival. The post-NAC pathological stage has previously been reported to be a major determi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7da23099d55a3dc7a18eb582b37b6bb
https://research.vumc.nl/en/publications/b36c8dc9-24fc-42a2-a1ef-426f4c66c3ad
https://research.vumc.nl/en/publications/b36c8dc9-24fc-42a2-a1ef-426f4c66c3ad
Autor:
Xin Shelly Wang, Run Wang, Mohamed Seif, Colin P.N. Dinney, Ashish M. Kamat, Amy Lim, Araceli Garcia-Gonzalez, Mary E. Westerman, Andrea Kokorovic, Neema Navai
Publikováno v:
The Journal of Sexual Medicine. 17:1995-2004
Background Cancer-related changes in sexual function (SF) negatively impact quality of life and intimate partner relationships. There is a lack of data regarding SF among patients who underwent radical cystectomy (RC). Aim To comparatively evaluate p